145
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Vanin 1 Gene Role in Modulation of iNOS/MCP-1/TGF-β1 Signaling Pathway in Obese Diabetic Patients

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 6745-6759 | Received 23 Aug 2022, Accepted 23 Nov 2022, Published online: 14 Dec 2022

References

  • Hall JE, Do Carmo JM, Da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15:367–385. doi:10.1038/s41581-019-0145-4
  • Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117:1859–1876. doi:10.1093/cvr/cvaa336
  • Starzak M, Stanek A, Jakubiak GK, Cholewka A, Cieślar G. Arterial stiffness assessment by pulse wave velocity in patients with metabolic syndrome and its components: is it a useful tool in clinical practice? Int J Environ Res Public Health. 2022;19:10368. doi:10.3390/ijerph191610368
  • Smith DM, Taylor W, Whitworth MK, Roberts S, Sibley C, Lavender T. The feasibility phase of a community antenatal lifestyle program [The Lifestyle Course (TLC)] for women with a body mass index (BMI) <30 kg / m (2.). Midwifery. 2015;31(2):280–287. doi:10.1016/j.midw.2014.10.002
  • Hou L, Jiang F, Huang B, et al. Dihydromyricetin ameliorates inflammation-induced insulin resistance via phospholipase C-CaMKK-AMPK signal pathway. Oxid Med Cell Longev. 2021;2021:8542809. doi:10.1155/2021/8542809
  • Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Visceral adiposity, not the abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008;57(5):1269–1275. doi:10.2337/db07-1378
  • Tulloch-Reid MK, Hanson RL, Sebring NG, Reynolds JC, Premkumar A, Genovese J. Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in African Americans. Obes Res Res. 2004;12(8):1352–1359. doi:10.1038/oby.2004.170
  • Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–373. doi:10.1016/j.tcm.2015.10.004
  • Alwahsh SM, Dwyer BJ, Forbes S, Thiel DH, Lewis PJ, Ramadori G. Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome. Int J Mol Sci. 2017;18(2):285. doi:10.3390/ijms18020285
  • Rodríguez-Correa E, González-Pérez I, Clavel-Pérez PI, Contreras-Vargas Y, Carvajal K. Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: what is the best choice? Nutr Diabetes. 2020;10(1):24. doi:10.1038/s41387-020-0127-4
  • Kwon Y, Kim JH, Ha EK, et al. Serum YKL-40 levels are associated with the atherogenic index of plasma in children. Mediators Inflamm. 2020;2020:8713908. doi:10.1155/2020/8713908
  • Viktorinova A, Malickova D, Svitekova K, Choudhury S, Krizko M. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes. Diabetes Res Clin Pract. 2021;176:108858. doi:10.1016/j.diabres.2021.108858
  • Kaneva AM, Potolitsyna NN, Bojko ER. Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile. Arch Physiol Biochem. 2017;123(1):16–22. doi:10.1080/13813455.2016.1195411
  • Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851. doi:10.5114/aoms.2016.58928
  • Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439–443.
  • Stępień M, Stępień A, Wlazeł RN, Paradowski M, Banach M, Rysz J. Obesity indices and inflammatory markers in obese non-diabetic normo-and hypertensive patients: a comparative pilot study. Lipids Health Dis. 2014;13(1):29–35. doi:10.1186/1476-511X-13-29
  • Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax. 2004;59:483–487. doi:10.1136/thx.2003.017640
  • Rother KI. Diabetes treatment-bridging the divide. N Engl J Med. 2007;356(15):1499–1501. doi:10.1056/NEJMp078030
  • Elgizawy HA, Ali AA, Hussein MA. Resveratrol: isolation, and its nanostructured lipid carriers, inhibits cell proliferation, induces cell apoptosis in certain human cell lines carcinoma and exerts protective effect against paraquat-induced hepatotoxicity. J Med Food. 2021;24(1):89–100. doi:10.1089/jmf.2019.0286
  • Hussein MA. Synthesis of some novel triazoloquinazolines and triazinoquinazolines and their evaluation for anti-inflammatory activity. Med Chem Res. 2012;21(8):1876–1886. doi:10.1007/s00044-011-9707-0
  • Abdel Maksoud HA, Elharrif MG, Mahfouz MK, Omnia MA, Abdullah MH, Eltabey ME. Biochemical study on occupational inhalation of benzene vapours in petrol station. Resp Med Case Rep. 2019;27:1–4. doi:10.1016/j.rmcr.2019.100836
  • El Gizawy HA, Abo-Salem HM, Ali AA, Hussein MA. Phenolic profiling and therapeutic potential of certain isolated compounds from parkia roxburghii against AChE activity as well as GABAAα5, GSK-3β, and p38α MAP-kinase genes. ACS Omega. 2021;6(31):20492–20511. doi:10.1021/acsomega.1c02340
  • Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem. 2005;280:7511–7518. doi:10.1074/jbc.M411871200
  • Yamashita N, Yashiro M, Ogawa H, et al. Metabolic pathway catalyzed by vanin-1 pantetheinase plays a suppressive role in influenza virus replication in human alveolar epithelial A549 cells. Biochem Biophys Res Commun. 2017;489(4):466–471. doi:10.1016/j.bbrc.2017.05.172
  • Chen S, Zhang W, Sun C, et al. Systemic nanoparticle-mediated delivery of pantetheinase vanin-1 regulates lipolysis and adiposity in abdominal white adipose tissue. Adv Sci. 2021;8(12):e2101789. doi:10.1002/advs.202101789
  • Ferreira DW, Naquet P, Manautou JE. Influence of vanin-1 and catalytic products in liver during normal and oxidative stress conditions. Curr Med Chem. 2015;22(20):2407–2416. doi:10.2174/092986732220150722124307
  • Metwaly AM, Elmoghazy HM, Hussein MA, Abdel-Aziz A, Elmasry SA. CAPE improves vanin-1/AKT/miRNA-203 signaling pathways in DSS-induced ulcerative colitis. Biomed Res Ther. 2022;9(9):5313–5325. doi:10.15419/bmrat.v9i9.769
  • Baikpour M, Baikpour M, Hosseini M, Sarveazad A. Variations in levels of interleukins and adiponectin in normal and obese adults; a case-control study. JMP. 2017;2(2):56–62.
  • Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the expert committee on the diagnosis and classification of diabetes mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract. 1999;44(1):21–26. doi:10.1016/s0168-8227(99)00008-x
  • Fossati P, Prencipe L. Serum triacylglycerols determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;1:2077–2080. doi:10.1093/clinchem/28.10.2077
  • Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;1974(4):470–475. doi:10.1093/clinchem/20.4.470
  • Burnstein M, Selvenick HR, Morfin R. Rapid method for isolation of lipoprotein from human serum with polyanions. J Lipid Res. 1970;11(11):583. doi:10.1016/S0022-2275(20)42943-8
  • Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005;21(3):389–395. doi:10.1152/physiolgenomics.00025.2005
  • Bae JC, Cho NH, Suh S, et al. Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: a community-based prospective study (Ansung-Ansan cohort 2001–12). J Diabetes. 2015;7(6):791–799. doi:10.1111/1753-0407.12248
  • Sung KC, Ryu S, Cheong ES, et al. All cause and cardiovascular mortality among Koreans: effects of obesity and metabolic health. Am J Prev Med. 2015;49:62–71. doi:10.1016/j.amepre.2015.02.010
  • Oh CM, Park JH, Chung HS, et al. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity. Medicine. 2020;99(38):e22036. doi:10.1097/MD.0000000000022036
  • Tsatsoulis A, Paschou SA. Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences. Curr Obes Rep. 2020;9(2):109–120. doi:10.1007/s13679-020-00375-0
  • Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233–244. doi:10.1056/NEJMoa1304501
  • Santhanam P, Masannat Y. Body mass index, mortality, and the obesity paradox in type 2 diabetes mellitus: the effect of hypertension. South Med J. 2014;107(6):361. doi:10.14423/01.SMJ.0000450710.46174.e2
  • Moffit JS, Koza-Taylor PH, Holland RD, et al. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Toxicol Appl Pharmacol. 2007;222(2):169–179. doi:10.1016/j.taap.2007.04.008
  • González MC, Corton JC, Cattley RC, Herrera E, Bocos C. Peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists down-regulate alpha2-macroglobulin expression by a PPAR alpha-dependent mechanism. Biochimie. 2009;91(8):1029–1035. doi:10.1016/j.biochi.2009.05.007
  • Chen X, Li M, Sun WP, et al. Agonist-induced down-regulation of hepatic glucocorticoid receptor via peroxisome proliferator-activated receptor in SD rats. Zhonghua Yi Xue Za Zhi. 2009;89(46):3276–3279.
  • Chen X, Li M, Sun W, et al. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats. Biochem Biophys Res Commun. 2008;368(4):865–870. doi:10.1016/j.bbrc.2008.01.152
  • Shimosaka T, Makarova KS, Koonin EV, Atomi H. Identification of dephospho-coenzyme A (dephospho-CoA) kinase in thermococcus kodakarensis and elucidation of the entire CoA biosynthesis pathway in archaea. mBio. 2019;10(4):e01146–19. doi:10.1128/mBio.01146-19
  • Roisin-Bouffay C, Castellano R, Valéro R, Chasson L, Galland F, Naquet P. Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes. Diabetologia. 2008;51(7):1192–1201. doi:10.1007/s00125-008-1017-9
  • Nitto T, Inoue T, Node K. Alternative spliced variants in the pantetheinase family of genes expressed in human neutrophils. Gene. 2008;426(1–2):57–64. doi:10.1016/j.gene.2008.08.019
  • Dammanahalli KJ, Stevens S, Terkeltaub R. Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia. PLoS One. 2012;7(6):e39106. doi:10.1371/journal.pone.0039106
  • Nitto T, Onodera K. Linkage between coenzyme a metabolism and inflammation: roles of pantetheinase. J Pharmacol Sci. 2013;123(1):1–8. doi:10.1254/jphs.13r01cp
  • Rommelaere S, Millet V, Gensollen T, et al. PPAR alpha regulates the production of serum vanin-1 by liver. FEBS Lett. 2013;587(22):3742–3748. doi:10.1016/j.febslet.2013.09.046
  • Van Diepen JA, Jansen PA, Ballak DB, et al. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism. J Hepatol. 2014;61(2):366–372. doi:10.1016/j.jhep.2014.04.013
  • Martin PG, Guillou H, Lasserre F, et al. Novel aspects of PPAR-alpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology. 2007;45(3):767–777. doi:10.1002/hep.21510
  • Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003;65:261–311. doi:10.1146/annurev.physiol.65.092101.142528
  • Yu S, Viswakarma N, Batra SK, Samabasiva RM, Reddy JK. Identification of promethin and PGLP as two novel up-regulated genes in PPAR-gamma1-induced adipogenic mouse liver. Biochimie. 2004;86:743–761. doi:10.1016/j.biochi.2004.09.015
  • Abdel-Gawad SM, Ghorab MM, El-Sharief AMSh, El-Telbany FA, Abdel-Alla M. Design, synthesis, and antimicrobial activity of some new pyrazolo[3,4-d]pyrimidines. Heteroatom Chem. 2003;14:530–534. doi:10.1002/hc.10187
  • Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55:560–578. doi:10.1007/s10620-009-1081-0
  • Motomura W, Yoshizaki T, Takahashi N, et al. Analysis of vanin-1 upregulation and lipid accumulation in hepatocytes in response to a high-fat diet and free fatty acids. J Clin Biochem Nutr. 2012;51(3):163–169. doi:10.3164/jcbn.12-06
  • Hussein MA, Ismail NEM, Mohamed AH, Borik RM, Ali AA, Mosaad YO. Plasma phospholipids: a promising simple biochemical parameter to evaluate COVID-19 infection severity. Bioinform Biol Insights. 2021;15:1–14. doi:10.1177/11779322211055891
  • Boshra SA, Hussein MA. Cranberry extract as a supplemented food in treatment of oxidative stress and breast cancer induced by N-Methyl-N-Nitrosourea in female virgin rats. Int J Phytomedicine. 2016;8(2):217–227.
  • El-Gizawy HA, Hussein MA. Fatty acids profile, nutritional values, anti-diabetic and antioxidant activity of the fixed oil of malvaparviflora growing in Egypt. Int J Phytomedicine. 2015;7:219–230.
  • Gobba NAEK, Hussein A, El Sharawy DE, Hussein MA. The potential hazardous effect of exposure to iron dust in Egyptian smoking and nonsmoking welders. Arch Environ Occup Health. 2018;73(3):189–202. doi:10.1080/19338244.2017.1314930
  • Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol. 2010;47(3):231–236. doi:10.1007/s00592-009-0143-2
  • Ley SH, Harris SB, Connelly PW. Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin Chem. 2010;56(4):666–670. doi:10.1373/clinchem.2009.136994
  • Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPAR-alpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5(6):426–437. doi:10.1016/j.cmet.2007.05.002
  • Li Y, Wong K, Giles A, et al. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology. 2014;146(2):539–49.e7. doi:10.1053/j.gastro.2013.10.059
  • Kaskow BJ, Proffitt JM, Blangero J, Moses EK, Abraham LJ. Diverse biological activities of the vascular non-inflammatory molecules - the Vanin pantetheinases. Biochem Biophys Res Commun. 2012;417(2):653–658. doi:10.1016/j.bbrc.2011.11.099
  • Jansen PA, Kamsteeg M, Rodijk-Olthuis D, et al. Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines. J Invest Dermatol. 2009;129(9):2167–2174. doi:10.1038/jid.2009.67
  • Lu H, Zhang A, Wen D, et al. Plasma vanin-1 as a novel biomarker of sepsis for trauma patients: a prospective multicenter cohort study. Infect Dis Ther. 2021;10(2):739–751. doi:10.1007/s40121-021-00414-w
  • Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol. 2000;59(1):95–104. doi:10.1016/s0006-2952(99)00301-9
  • Naquet P, Pitari G, Duprè S, Galland F. Role of the Vnn1 pantetheinase in tissue tolerance to stress. Biochem Soc Trans. 2014;42(4):1094–1100. doi:10.1042/BST20140092
  • Salam OM. Modulation of inflammatory paw oedema by cysteamine in the rat. Pharmacol Res. 2002;45(4):275–284. doi:10.1006/phrs.2002.0955
  • Berruyer C, Martin FM, Castellano R, Macone A, Malergue F, Garrido-Urbani S. Vanin-1−/− mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol. 2004;24:7214–7224. doi:10.1128/MCB.24.16.7214-7224.2004
  • Awad MA, Aldosari SR, Abid MR. Genetic alterations in oxidant and anti-oxidant enzymes in the vascular system. Front Cardiovasc Med. 2018;5:107. doi:10.3389/fcvm.2018.00107
  • Li H, Horke S, Förstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237(1):208–219. doi:10.1016/j.atherosclerosis.2014.09.001
  • Williams SM, Eleftheriadou A, Alam U, Cuthbertson DJ, Wilding JPH. Correction to cardiac autonomic neuropathy in obesity, metabolic syndrome and prediabetes: a narrative review. Diabetes Ther. 2019;10(6):2023. doi:10.1007/s13300-019-00705-z
  • Zhang B, Lo C, Shen L, et al. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood. 2011;117(17):4569–4579. doi:10.1182/blood-2010-09-304931
  • Elsalakawy WA, Ali MA, Hegazy MG, Farweez BA. Value of vanin-1 assessment in adult patients with primary immune thrombocytopenia. Platelets. 2014;25(2):86–92. doi:10.3109/09537104.2013.782484
  • Tinahones FJ, Murri-Pierri M, Garrido-Sánchez L, et al. Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity. 2009;17(2):240–246. doi:10.1038/oby.2008.536
  • Bausenwein J, Serke H, Eberle K, et al. Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women. Mol Hum Reprod. 2010;16(2):117–124. doi:10.1093/molehr/gap078
  • Zhang R, Liu R, Zong W. Bisphenol S interacts with catalase and induces oxidative stress in mouse liver and renal cells. J Agric Food Chem. 2016;64(34):6630–6640. doi:10.1021/acs.jafc.6b02656
  • Ighodaro OM, Akinloy OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018;54:287–293. doi:10.1016/j.ajme.2017.09.001
  • Rindler PM, Plafker SM, Szweda LI, Kinter M. High dietary fat selectively increases catalase expression within cardiac mitochondria. J Biol Chem. 2013;288(3):1979–1990. doi:10.1074/jbc.M112.412890
  • Mehebik N, Jaubert AM, Sabourault D, Giudicelli Y, Ribière C. Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation. Am J Physiol Cell Physiol. 2005;289(2):C379–87. doi:10.1152/ajpcell.00320.2004
  • Ribière C, Jaubert AM, Sabourault D, Lacasa D, Giudicelli Y. Insulin stimulates nitric oxide production in rat adipocytes. Biochem Biophys Res Commun. 2002;291(2):394–399. doi:10.1006/bbrc.2002.6444
  • Martin F, Penet MF, Malergue F, et al. Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. J Clin Invest. 2004;113(4):591–597. doi:10.1172/JCI19557
  • Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernandez N, Talamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J. 2005;26:390–397.
  • McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol. 2007;293:R821–R828.
  • Lu M, Li P, Pferdekamper J, et al. Inducible nitric oxide synthase deficiency in myeloid cells does not prevent diet-induced insulin resistance. Mol Endocrinol. 2010;24:1413–1422.
  • Torres SH, De Sanctis JB, Hernandez N, Finol HJ. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol. 2004;181:419–427.
  • Lien CC, Au LC, Tsai YL, Ho LT, Juan CC. Short-term regulation of tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes is mediated through the inducible nitric oxide synthase/nitric oxide-dependent pathway. Endocrinology. 2009;150(11):4892–4900. doi:10.1210/en.2009-0403
  • Juan CC, Lien CC, Chang CL, Huang YH, Ho LT. Involvement of iNOS and NO in TNF-alpha-downregulated resistin gene expression in 3T3-L1 adipocytes. Obesity. 2008;16(6):1219–1225. doi:10.1038/oby.2008.200
  • Batra J, Chatterjee R, Ghosh B. Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis. Indian J Biochem Biophys. 2007;44(5):303–309.